Skip to content
2000
Volume 7, Issue 3
  • ISSN: 1871-5214
  • E-ISSN: 1875-6018

Abstract

Two different series of N-substituted heteroaromatic compounds related to clotrimazole structure were synthesized. In one series ortho-cholortrityl moiety of clotrimazole was replaced by trityl, mono or dimethoxy trityl (series c). In the second series the imidazole ring of clotrimazole was also replaced by benzimidazole (series d). Chemical structures of all the new compounds were confirmed by spectrophotometric methods. These compounds docked into the active site of MT-CYP51 (PDB code, 1E9X) using Autodock tools software. They showed good affinity for the enzyme comparable to clotrimazole. Antifungal activities for these compounds were evaluated against Trichophyton mentagrophytes, Microsporum gypseum and Candida albicans using PDA as media, CHCl3 or DMSO as solvents and agar dilution assay as method. In this method 1-triphenylmethyl-imidazole (1c), 1-(bis-4-methoxyphenyl)-phenylmethyl-benzimidazole (6d) and 1-(4-methoxyphenyl)-diphenylmethyl-imidazole (2c) showed 100%, 90% and 70% activity respectively. In the second step all of the derivatives also were evaluated against Trichophyton rubrum, Microsporum canis and Epidermaphyton floccosum using PDA medium by agar dilution method. In this method 1-triphenylmethyl-imidazole (1c) and 1-(bis-4- methoxyphenyl)-phenylmethyl-benzimidazole (6d) showed 100% and 1-(4-methoxyphenyl)-diphenylmethyl-imidazole (2c) and 1-(bis-4-methoxyphenyl)-phenylmethyl-imidazole (3c) more than 75% activity against the fungi. Then the most active analogues (1c, 2c and 6d) were tested in RPMI 1640 medium which showed desirable biological activity in comparison to clotrimazole.

Loading

Article metrics loading...

/content/journals/aiamc/10.2174/187152108784911250
2008-07-01
2025-05-25
Loading full text...

Full text loading...

/content/journals/aiamc/10.2174/187152108784911250
Loading

  • Article Type:
    Research Article
Keyword(s): antifungal activity; benzimidazole; clotrimazole; Imidazole
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test